Fulcrum Equity Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,904
Closed -$256K 133
2021
Q4
$256K Sell
1,904
-48
-2% -$6.9K 0.1% 151
2021
Q3
$267K Buy
+1,952
New +$246K 0.1% 146

Other funds holding DXCM

Fulcrum Equity Management's DXCM Position: Q1 2022 in Review

Fulcrum Equity Management sold out of DexCom (DXCM) in Q1 2022, closing a stake of 1,904 shares — an estimated $256K sold.

Fulcrum Equity Management first reported a position in DXCM in Q3 2021 and held it in 2 quarters. The position peaked at $267K in Q3 2021. 861 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

  • Fulcrum Equity Management reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
  • Fulcrum Equity Management sold 1,904 DexCom shares in Q1 2022, an estimated $256K.
  • Fulcrum Equity Management first reported a position in DexCom in Q3 2021 and held it in 2 quarters.
  • Fulcrum Equity Management's DexCom position peaked at $267K in Q3 2021.
  • 861 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Fulcrum Equity Management's 13F filing for Q1 2022, filed 15 Apr 2022.